+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Prefilled Syringes Market by Design, Product Type, Therapeutic, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968725
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Prefilled Syringes Market grew from USD 13.92 billion in 2023 to USD 14.91 billion in 2024. It is expected to continue growing at a CAGR of 7.63%, reaching USD 23.29 billion by 2030.

The global market for prefilled syringes is expanding rapidly, driven by their necessity in modern healthcare settings for enhanced drug delivery efficiency and patient safety. Prefilled syringes are defined as single-use, disposable devices preloaded with pharmaceutical substances, designed for safe and convenient administration. They are vital in applications ranging from chronic disease management, like diabetes, to emergency care and vaccination programs. Healthcare providers and patients benefit from their accuracy, reduced medication errors, and ease of use, promoting adherence importantly across the aging population. The market is significantly influenced by factors such as the increasing prevalence of chronic diseases, advancements in biologics, and growing demand for self-administration and home-based care. The latest opportunities lie in the rapid adoption of technologies like smart syringes, which incorporate connectivity for compliance monitoring and data analytics, aligning with healthcare digitization trends. However, limitations persist, such as regulatory hurdles, high development costs, and issues related to drug stability. Market growth is also challenged by the availability of alternative drug delivery systems and environmental concerns regarding plastic waste. Nonetheless, areas ripe for innovation include biocompatible materials to address environmental concerns and the development of dual-chamber technologies for drugs requiring reconstitution. Research avenues in enhancing needle safety and minimizing waste through advanced packaging and delivery systems also present significant growth potential. The nature of the prefilled syringe market is highly competitive, with key players focusing on geographical expansion, strategic collaborations, and product innovations. Businesses seeking growth should focus on overcoming regulatory and technological challenges by investing in R&D, fostering partnerships for innovative solutions, and expanding into emerging markets to capture untapped potential. Adapting to consumer preferences for eco-friendly options and leveraging data-driven insights to enhance user experience will be crucial in navigating this evolving landscape.

Understanding Market Dynamics in the Prefilled Syringes Market

The Prefilled Syringes Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing adoption of self-care devices and digitalization
    • Rapid growth in generic products
    • Rising expenditure on development of efficient healthcare infrastructure
  • Market Restraints
    • Dearth of prefilled syringes with integrated safety features
  • Market Opportunities
    • Growing healthcare infrastructure across emerging countries
    • Increasing adoption of wearable drug delivery technologies
  • Market Challenges
    • Availability of cost effective alternatives

Exploring Porter’s Five Forces for the Prefilled Syringes Market

Porter’s Five Forces framework further strengthens the insights of the Prefilled Syringes Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Prefilled Syringes Market

External macro-environmental factors deeply influence the performance of the Prefilled Syringes Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Prefilled Syringes Market

The Prefilled Syringes Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Prefilled Syringes Market

The Prefilled Syringes Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Prefilled Syringes Market

The Prefilled Syringes Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Prefilled Syringes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Gerresheimer AG, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson, Mylan N.V. by Viatris Inc., Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., Samsung Bioepis, Sanofi, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Prefilled Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Design
    • Customized Prefilled Syringes
    • Dual-Chamber Prefilled Syringes
    • Single-Chamber Prefilled Syringes
  • Product Type
    • Glass Pre Filled Syringes
    • Plastic Pre Filled Syringes
  • Therapeutic
    • Arthritis Pre Filled Syringes
    • Heparin Pre Filled Syringes
    • Insulin Pre Filled Syringes
    • PCSK9 Inhibitor Pre Filled Syringes
    • Vaccine Pre Filled Syringes
  • Application
    • Anaphylaxis
    • Cancer
    • Diabetes
    • Ophthalmology
    • Rheumatoid Arthritis
    • Thrombosis
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Prefilled Syringes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of self-care devices and digitalization
5.1.1.2. Rapid growth in generic products
5.1.1.3. Rising expenditure on development of efficient healthcare infrastructure
5.1.2. Restraints
5.1.2.1. Dearth of prefilled syringes with integrated safety features
5.1.3. Opportunities
5.1.3.1. Growing healthcare infrastructure across emerging countries
5.1.3.2. Increasing adoption of wearable drug delivery technologies
5.1.4. Challenges
5.1.4.1. Availability of cost effective alternatives
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Prefilled Syringes Market, by Design
6.1. Introduction
6.2. Customized Prefilled Syringes
6.3. Dual-Chamber Prefilled Syringes
6.4. Single-Chamber Prefilled Syringes
7. Prefilled Syringes Market, by Product Type
7.1. Introduction
7.2. Glass Pre Filled Syringes
7.3. Plastic Pre Filled Syringes
8. Prefilled Syringes Market, by Therapeutic Category
8.1. Introduction
8.2. Arthritis Pre Filled Syringes
8.3. Heparin Pre Filled Syringes
8.4. Insulin Pre Filled Syringes
8.5. PCSK9 Inhibitor Pre Filled Syringes
8.6. Vaccine Pre Filled Syringes
9. Prefilled Syringes Market, by Application
9.1. Introduction
9.2. Anaphylaxis
9.3. Cancer
9.4. Diabetes
9.5. Ophthalmology
9.6. Rheumatoid Arthritis
9.7. Thrombosis
10. Americas Prefilled Syringes Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Prefilled Syringes Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Prefilled Syringes Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Becton, Dickinson and Company
14.1.2. Catalent, Inc.
14.1.3. Dätwyler Holding Inc.
14.1.4. Elcam Medical Italy Spa
14.1.5. Fresenius Kabi
14.1.6. Gerresheimer AG
14.1.7. MedXL Inc.
14.1.8. Nipro Corporation
14.1.9. Novartis AG
14.1.10. Schott AG
14.1.11. Stevanato Group
14.1.12. Terumo Corporation
14.1.13. Unilife Corporation
14.1.14. Weigao Holding Company Limited
14.1.15. West Pharmaceutical Services, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. PREFILLED SYRINGES MARKET RESEARCH PROCESS
FIGURE 2. PREFILLED SYRINGES MARKET SIZE, 2023 VS 2030
FIGURE 3. PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PREFILLED SYRINGES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PREFILLED SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PREFILLED SYRINGES MARKET DYNAMICS
FIGURE 7. PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2030 (%)
FIGURE 8. PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2023 VS 2030 (%)
FIGURE 12. PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PREFILLED SYRINGES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 6. PREFILLED SYRINGES MARKET SIZE, BY CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 10. PREFILLED SYRINGES MARKET SIZE, BY GLASS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PREFILLED SYRINGES MARKET SIZE, BY PLASTIC PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 13. PREFILLED SYRINGES MARKET SIZE, BY ARTHRITIS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PREFILLED SYRINGES MARKET SIZE, BY HEPARIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PREFILLED SYRINGES MARKET SIZE, BY INSULIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PREFILLED SYRINGES MARKET SIZE, BY PCSK9 INHIBITOR PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PREFILLED SYRINGES MARKET SIZE, BY VACCINE PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. PREFILLED SYRINGES MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PREFILLED SYRINGES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PREFILLED SYRINGES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PREFILLED SYRINGES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PREFILLED SYRINGES MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 39. CANADA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 41. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 43. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 61. CHINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 63. CHINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 65. INDIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 67. INDIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 73. JAPAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 75. JAPAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 97. THAILAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 99. THAILAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 110. DENMARK PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 114. EGYPT PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 116. EGYPT PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 118. FINLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 120. FINLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 122. FRANCE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 126. GERMANY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 134. ITALY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 136. ITALY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 146. NORWAY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 148. NORWAY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 150. POLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 152. POLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 154. QATAR PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 156. QATAR PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 170. SPAIN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 172. SPAIN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 182. TURKEY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 184. TURKEY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC CATEGORY, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. PREFILLED SYRINGES MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Prefilled Syringes market, which are profiled in this report, include:
  • AbbVie Inc.
  • AptarGroup, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Catalent, Inc. by Novo Holdings A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • Mylan N.V. by Viatris Inc.
  • Nipro Europe Group Companies
  • Novartis AG
  • Pfizer, Inc.
  • Samsung Bioepis
  • Sanofi
  • SCHOTT Pharma
  • Shandong Weigao Group Medical Polymer Company Limited
  • SHL Medical AG
  • Stevanato Group
  • Terumo Medical Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

Methodology

Loading
LOADING...

Table Information